Dermatology & Mohs Surgery Billing Integrity Diagnostic
Eliminate automated recoupments on same-day biopsy consults (CPT 11102-11107 with Modifier 25), optimize Mohs stages (CPT 17311-17315), and protect reconstructive repair margins.
Dermatology practices face relentless payer audit scrutiny surrounding same-day biopsies (CPT 11102) billed alongside full-body skin cancer screenings (99213/99214 with Modifier 25). Commercial payers frequently bundle the E/M visit or reject complex reconstructive flaps and grafts (CPT 14000-14061) performed after Mohs micrographic excisions. Our forensic dermatology audit cross-references operative notes, margins, and pathology staging to recapture unbilled stage tissue blocks and protect procedural fee schedules.
Audit red flags
- Automatic denial of E/M Modifier 25 whenever a lesion biopsy or cryotherapy is performed on the same day.
- Carrier stripping complex reconstructive repair codes under National Correct Coding Initiative (NCCI) edits.
- Payer downcoding Mohs surgery stages due to vague histopathologic mapping descriptions in operative records.
- Unbundling denials on intermediate closures billed with benign lesion excisions (CPT 11400-11446).
Audit action plan
- 1. Mohs Operative Note Documentation Scrub — Audit surgeon documentation to ensure tissue block maps, depth, margin status, and defect measurements meet AAD criteria.
- 2. Modifier 25 Independent Medical Decision Making Verification — Isolate separate clinical paragraphs documenting full-body skin exam findings distinct from the biopsy procedure.
- 3. NCCI PTP Edit Dispute Submissions — File formal appeals using Modifier 59 or -XS to prove reconstructive closures occurred at distinct anatomic sites.
Codes reviewed
- 17311 / 17312 — Mohs Surgery, Head/Neck/Hands (Stage 1 / Additional Stages)
- 11102 / 11104 — Tangential / Punch Biopsy of Single Lesion
- 13131 / 13132 — Complex Facial Reconstruction Repair (1.1cm to 2.5cm)
- 17000 / 17003 — Destruction of Premalignant Actinic Keratoses
Frequently asked questions
Can a dermatologist bill an office visit and a biopsy on the same day?
Yes. If the patient presented for an overall skin examination or a distinct problem, and the decision to biopsy was made during that encounter, Modifier 25 is fully warranted under AMA and CMS guidelines.
Why are commercial payers downcoding complex repairs to intermediate repairs?
Payers audit operative reports for specific documentation of extensive undermining, debridement, or layered retention sutures. Without these specific surgical descriptions, automated algorithms downcode the closure.